Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy.

[1]  Nader Rifai,et al.  Handbook of Lipoprotein Testing , 2001 .

[2]  J. Viikari,et al.  Reduced mildly oxidized LDL in young female athletes. , 2000, Atherosclerosis.

[3]  J. Viikari,et al.  Large-artery elastic properties in young men : relationships to serum lipoproteins and oxidized low-density lipoproteins. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  T. Vasankari,et al.  Reduced oxidized LDL levels after a 10-month exercise program , 1998 .

[5]  S. Ylä-Herttuala,et al.  Is oxidized low-density lipoprotein present in vivo? , 1998, Current opinion in lipidology.

[6]  J. Mehta,et al.  Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. , 1998, Biochemical and biophysical research communications.

[7]  T. Lehtimäki,et al.  Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. , 1998, Clinical biochemistry.

[8]  T. Aoyama,et al.  High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1). , 1998, Biochemical and biophysical research communications.

[9]  S. Hirose,et al.  Unique repetitive sequence and unexpected regulation of expression of rat endothelial receptor for oxidized low-density lipoprotein (LOX-1). , 1998, The Biochemical journal.

[10]  T. Lehtimäki,et al.  In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. , 1997, Journal of the American College of Cardiology.

[11]  T. Vasankari,et al.  EFFECT OF WEIGHT REDUCTION ON LDL OXIDATION 747 , 1997 .

[12]  J. Kaprio,et al.  Familial aggregation of LDL oxidation. , 1997, Scandinavian journal of clinical and laboratory investigation.

[13]  D. Steinberg,et al.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.

[14]  T. Vasankari,et al.  Effects of acute prolonged exercise on-serum and LDL oxidation and antioxidant defences. , 1997, Free radical biology & medicine.

[15]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[16]  B. Nordestgaard,et al.  Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. , 1996, Circulation.

[17]  J. Kaprio,et al.  Low LDL oxidation in veteran endurance athletes , 1996, Scandinavian journal of medicine & science in sports.

[18]  A. Yeung,et al.  Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. , 1996, Circulation.

[19]  J. Boer,et al.  Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. , 1996, Atherosclerosis.

[20]  M. Ahotupa,et al.  Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. , 1996, Clinical biochemistry.

[21]  S. Devaraj,et al.  Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. , 1996, Clinical chemistry.

[22]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[23]  J. Fruchart,et al.  Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[24]  P. Poole‐Wilson,et al.  Lower patients' cholesterol now , 1995, BMJ.

[25]  U. de Faire,et al.  Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[26]  G. Bellomo,et al.  LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  V. Armstrong,et al.  Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease , 1994, The Lancet.

[28]  D. Kramsch,et al.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). , 1994, Journal of lipid research.

[29]  M. Naruszewicz,et al.  Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. , 1993, Biochimica et biophysica acta.

[30]  M. Lopes-Virella,et al.  Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers , 1993, International journal of clinical & laboratory research.

[31]  H. Esterbauer,et al.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL. , 1992, Free radical biology & medicine.

[32]  J. Graaf,et al.  LDL oxidation and coronary atherosclerosis , 1992, The Lancet.

[33]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[34]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[35]  A. Lusis,et al.  Minimally modified low density lipoprotein is biologically active in vivo in mice. , 1991, The Journal of clinical investigation.

[36]  R. Stocker,et al.  Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Territo,et al.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.

[38]  H. Esterbauer,et al.  Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein , 2009 .

[39]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[40]  H. Wieland,et al.  A simple specific method for precipitation of low density lipoproteins. , 1983, Journal of lipid research.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.